| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.67 | 0.0005 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0006 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.0006 |